Clinical Characteristics and Treatment Results of LMB/LMT Regimen in Children with Non-Hodgkin's Lymphoma

REFERENCES

• Greenlee R.T., Murray T., Bolden S., Wingo P.A. Cancer Statistics, 2000. CA Cancer J. Clin. 2000; 50: 7–33
   PubMed Web of Science ®Google Scholar
• Nachman J. Therapy for Childhood Non-Hodgkin's Lymphomas, Non-Lymphoblastic Type. Am. J. Pediatr. Hematol. Oncol. 1990; 12: 359–366
   PubMedGoogle Scholar
• Anderson J.R., Jenkin R.D.T., Wilson J.F., Kjeldsberg C.R., Sposto R., Chilcote R.R., Coccia P.F., Exelby P.R., Siegel S., Meadows A.T., Hammond G.D. Long Term Follow-Up of Patients Treated with COMP or LSA2-L2 Therapy for Childhood Non-Hodgkin's Lymphoma: A Report of CCG-551 from the Childrens Cancer Group. J. Clin. Oncol. 1993; 11: 1024–1032
   PubMed Web of Science ®Google Scholar
• Cairo M.S., Gerrard M., Patte C. A New Protocol for Treatment of Mature B-Cell Lymphoma/Leukemia (BCLL): FAB LMB96, a SFOP LMB96/CCG-5961/UKCCSG NHL9600 International Cooperative Study. Med. Pediatr. Oncol. 1997; 29: 357
   Google Scholar
• Patte C., Michon J., Behrendt H., Leverger G., Bergeron C., Robert A., Mechinaud F., Bertrand Y., Perel Y., Coze C., Nelken B. Results of the LMB 89 Protocol for Childhood B Cell Lymphoma and Leukemia (ALL). Med. Pediatr. Oncol. 1997; 29: 358
   Google Scholar
• Patte C. Non-Hodgkin's Lymphomas. Pediatric Oncology, C.R. Pinkerton, P.N. Plowman. Chapman and Hall, London 1997; 278–295
   Google Scholar
• Reiter A., Schrappe M., Tiemann M., Ludwig W.D., Yakisan E., Zimmermann M., Mann G., Chott A., Ebell W., Klingebiel T., Graf N., Kremens B., Müller-Weihrich S., Plüss H.J., Zintl F., Henze G., Riehm H. Improved Treatment Results in Childhood B-Cell Neoplasms with Tailored Intensification of Therapy: a Report of the BFM Group Trial NHL—BFM 90. Blood 1999; 94: 3294–3306
   PubMed Web of Science ®Google Scholar
• Reiter A., Schrappe M., Ludwig W.D., Tiemann M., Parwaresch R., Zimmermann M., Schirg E., Henze G., Schellong G., Gadner H., Riehm H. Intensive ALL-Type Therapy without Local Radiotherapy Provides a 90% Event-Free Survival for Children with T-Cell Lymphoblastic Lymphoma: a BFM Group Report. Blood 2000; 95: 416–421
   PubMed Web of Science ®Google Scholar
• Büyükpamukçu M., Sarıalioğlu F., Akyüz C., Çevik N. Combined Chemotherapy in 76 Children with Non-Hodgkin's Lymphoma Excluding Burkitt Lymphoma. Br. J. Cancer 1987; 56: 625–628
   PubMed Web of Science ®Google Scholar
• Sarialioğlu F., Büyükpamukçu M., Akyüz C., Kutluk T. Combined Chemotherapy in Non-Burkitt's Non-Hodgkin's Lymphoma: Long Term Results of a Unified Protocol. Med. Pediatr. Oncol. 1993; 21: 532
   Google Scholar
• Wessels G., Hesseling P.B. High Dose Intense Chemotherapy in South African Children with B-Cell Lymphoma: Morbidity, Supportive Measures and Outcome. Med. Pediatr. Oncol. 2000; 34: 143–146
   PubMedGoogle Scholar
• Kavan P., Kabickova E., Gajdos P., Koutecky J., Kodet R., McClain K.L. Treatment of Pediatric B-Cell Non-Hodgkin's Lymphomas at the Motol Hospital in Prague, Czech Republic: Results Based on the NHL BFM 90 Protocols. Pediatr. Hematol. Oncol. 1999; 16: 201–212
   PubMed Web of Science ®Google Scholar
• Murphy S.B., Fairclough D.L., Hutchinson R.E., Berard C.W. Non-Hodgkin's Lymphoma of Childhood: An Analysis of the Histology, Staging and Response to Treatment of 338 Cases at a Single Institution. J. Clin. Oncol. 1989; 7: 186–193
   PubMed Web of Science ®Google Scholar
• Bergeron C., Patte C., Leverger G., Gentet J.C., Gandemer V., Perel Y., De Lumley L., Demécoq F., Dusol F., Baruchel A. Treatment of Childhood Lymphoblastic Lymphomas: Results of the SFOP LMT89 Protocol (Societe Française d'Oncologie Pediatrique). Med. Pediatr. Oncol. 1997; 29: 356
   Google Scholar
• Peto R., Pike M.C., Armitage P., Breslow N.E., Cox D.R., Howard S.V., Mantel N., McPherson K., Peto J., Smith P.G. Design and Analysis of Randomized Clinical Trials Requiring Prolonged Observation of Each Patient. Br. J. Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Hiçsönmez G., Büyükpamukçu M. Pediatric Hematology and Oncology in Turkey. Forum 1994; 1: 4–8
   Google Scholar
• Büyükpamukçu M. Non-Hodgkin's Lymphomas. Cancer in Children, P. Voute, C. Kalifa, A. Barrett. Oxford University Press, Oxford 1998; 119–136
   Google Scholar
• Kutluk T., Sarıalioğlu F., Göğüş S., Akyüz C., Büyükpamukçu M. Burkitt's Lymphoma in Turkish Children: A Retrospective Analysis of 104 Cases. Turk. J. Cancer 1993; 23: 81–89
   Google Scholar
• Al-Attar A., Al-Mondhiry H., Al-Bahrani Z., Al-Saleem T. Burkitt's Lymphoma in Iraq: Clinical and Pathological Study of 47 Patients. Int. J. Cancer 1979; 23: 14–17
   PubMed Web of Science ®Google Scholar
• Anaissie E., Geha S., Allam C., Jabbour J., Khalyl M., Salem P. Burkitt's Lymphoma in the Middle East: A Study of 34 Cases. Cancer 1985; 56: 2539–2543
   PubMed Web of Science ®Google Scholar
• Shad A., Magrath I. Malignant Non-Hodgkin's Lymphoma in Children. Principles and Practice of Pediatric Oncology, P.A. Pizzo, D.G. Poplack. Lippincott, Philadelphia, PA 1997; 545–587
   Google Scholar
• Samuelsson B.O., Ridell B., Röckert L., Gustafsson G., Marky I. Non-Hodgkin Lymphoma in Children: A 20-Year Population Based Epidemiologic Study in Western Sweden. J. Pediatr. Hematol. Oncol. 1999; 21: 103–110
   PubMed Web of Science ®Google Scholar
• Murphy S.B. Modern Trends in Non-Hodgkin Lymphoma. J. Pediatr. Hematol. Oncol. 1999; 21: 87–88
   PubMed Web of Science ®Google Scholar
• Patte C., Philip T., Rodary C., Bernard A., Zucker J.M., Bernard J.L., Robert A., Rialland X., Benz-Lemoine E., Demecoq F., Bayle C., Lemerle C. Improved Survival Rate in Children with Stage III and IV B-Cell Non Hodgkin's Lymphoma and Leukemia Using a Multiagent Chemotherapy: Results of a Study of 114 Children from the French Pediatric Oncology Society. J. Clin. Oncol. 1986; 4: 1219–1226
   PubMed Web of Science ®Google Scholar
• Patte C., Philip T., Rodary C., Zucker J.M., Behrendt H., Gentet J.C., Lamagnère J.P., Otten J., Dufillot D., Pein F., Caillou B., Lemerle J. High Survival Rate in Advanced-Stage B-Cell Lymphomas and Leukemias without CNS Involvement with a Short Intensive Polychemotherapy: Results from the French Pediatric Oncology Society of a Randomized Trial of 216 Children. J. Clin. Oncol. 1991; 9: 123–132
   PubMed Web of Science ®Google Scholar
• Atra A., Imeson J.D., Hobson R., Gerrard M., Hann I.M., Eden O.B., Carter R.L., Pinkerton C.R. Improved Outcome in Children with Advanced Stage B-Cell Non-Hodgkin's Lymphoma (B-NHL): Results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 Protocol. Br. J. Cancer 2000; 82: 1396–1402
   PubMed Web of Science ®Google Scholar
• Şakiroğlu C., Patte C., Michon J., Ansoborlo S., Plouvier E., Babin-Boilletot A., Baruchel A. Use of Uricozyme® and Occurrence of Metabolic Problems During Initial Phase of the LMB89 Protocol. Med. Pediatr. Oncol. 1997; 29: 331
   Google Scholar
• Mahmoud H.H., Leverger G., Patte C., Harvey E., Lascombers F. Advances in the Management of Malignancy Associated Hyperuricemia. Br. J. Cancer 1998; 77: 18–20
   PubMed Web of Science ®Google Scholar